Clinical characteristics of patients treated with immune checkpoint inhibitors in EGFR-mutant non-small cell lung cancer: CS-Lung-003 prospective observational registry study.

Kuribayashi T, Ohashi K, Nishii K, Ninomiya K, Tsubata Y, Ishikawa N, Kodani M, Kanaji N, Yamasaki M, Fujitaka K, Kuyama S, Takigawa N, Fujimoto N, Kubota T, Inoue M, Fujiwara K, Harita S, Takata I, Takada K, Okawa S, Kiura K, Hotta K

Open source

DOI: 10.1007/s00432-024-05618-4
Published: 2024 Feb 12
Container: Journal of cancer research and clinical oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00432-024-05618-4,
  title = {Clinical characteristics of patients treated with immune checkpoint inhibitors in EGFR-mutant non-small cell lung cancer: CS-Lung-003 prospective observational registry study.},
  author = {Kuribayashi T and Ohashi K and Nishii K and Ninomiya K and Tsubata Y and Ishikawa N and Kodani M and Kanaji N and Yamasaki M and Fujitaka K and Kuyama S and Takigawa N and Fujimoto N and Kubota T and Inoue M and Fujiwara K and Harita S and Takata I and Takada K and Okawa S and Kiura K and Hotta K},
  year = {2024},
  journal = {Journal of cancer research and clinical oncology},
  doi = {10.1007/s00432-024-05618-4},
  url = {https://doi.org/10.1007/s00432-024-05618-4}
}

RIS

TY  - JOUR
TI  - Clinical characteristics of patients treated with immune checkpoint inhibitors in EGFR-mutant non-small cell lung cancer: CS-Lung-003 prospective observational registry study.
AU  - Kuribayashi T
AU  - Ohashi K
AU  - Nishii K
AU  - Ninomiya K
AU  - Tsubata Y
AU  - Ishikawa N
AU  - Kodani M
AU  - Kanaji N
AU  - Yamasaki M
AU  - Fujitaka K
AU  - Kuyama S
AU  - Takigawa N
AU  - Fujimoto N
AU  - Kubota T
AU  - Inoue M
AU  - Fujiwara K
AU  - Harita S
AU  - Takata I
AU  - Takada K
AU  - Okawa S
AU  - Kiura K
AU  - Hotta K
PY  - 2024
JO  - Journal of cancer research and clinical oncology
DO  - 10.1007/s00432-024-05618-4
UR  - https://doi.org/10.1007/s00432-024-05618-4
ER  -

APA

T, K., K, O., K, N., K, N., Y, T., N, I., M, K., N, K., M, Y., K, F., S, K., N, T., N, F., T, K., M, I., K, F., S, H., I, T., K, T., S, O., K, K., & K, H. (2024). Clinical characteristics of patients treated with immune checkpoint inhibitors in EGFR-mutant non-small cell lung cancer: CS-Lung-003 prospective observational registry study.. Journal of cancer research and clinical oncology. https://doi.org/10.1007/s00432-024-05618-4

Source records

pubmed · retrieved 2026-09-26T23:40:03.325Z
europe-pmc · retrieved 2026-09-26T23:40:03.337Z